Identification of quantitative factors and support tools to reduce the risk of adverse events after oncological treatments
Ente Finanziatore: AIRC MFAG 27480 (Location Matters) Direzione Scientifica, Fondazione IRCCS Istituto Nazionale dei Tumori
Principal Investigator: Dott.ssa De Santis Maria Carmen
Co Principal Investigator: Dott.ssa Vallerio Paola
Data di inizio:
Struttura Principale: Data Science
PI: Alessandro Cicchetti
The study focuses on the use of tools not yet included in clinical practice, or on the extraction of subclinical parameters from standard medical equipment, with the aim of determining tolerable doses in radiotherapy or pharmacological treatments. This approach seeks to reduce the occurrence of adverse events that compromise treatment effectiveness and patient survival.
The main topics addressed so far include cardiotoxicity in patients with lung or breast cancer, and the vascular effects of anti-VEGF therapies in tumor-agnostic populations.
Principal Investigator Dr. De Santis Maria Carmen
Co Principal Investigator Dr. Vallerio Paola
Dr. Veronese Chiara
Struttura Principale: Data Science
Research Area, Complex Structure
Radiation Oncology Unit
Clinical Area, Complex Structure
Oncologia Medica 1
Area Clinica, Struttura complessa
Pulmonology Unit
Clinical Area, Departmental Simple Structure
Cardiologia
Struttura complessa
Last update: 27/08/2025